Sovarnum Capital’s Oracle ORCL Stock Holding History

Sovarnum Capital’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,200	Closed	-$766K	–	116
2017 Q4	$766K	Buy	+16,200	New	+$795K	0.52%	56

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sovarnum Capital's ORCL Position: Q2 2018 in Review

Sovarnum Capital sold out of Oracle (ORCL) in Q2 2018, closing a stake of 10,000 shares — an estimated $458K sold.

Sovarnum Capital first reported a position in ORCL in Q4 2017 and held it in 2 quarters. The position peaked at $458K in Q1 2018. 1,704 funds tracked by Wall St. Rank hold ORCL as of Q2 2018.

Sovarnum Capital reported no remaining Oracle position as of Q2 2018 after selling out during the quarter.
Sovarnum Capital sold 10,000 Oracle shares in Q2 2018, an estimated $458K.
Sovarnum Capital first reported a position in Oracle in Q4 2017 and held it in 2 quarters.
Sovarnum Capital's Oracle position peaked at $458K in Q1 2018.
1,704 funds tracked by Wall St. Rank held Oracle as of Q2 2018.

Based on Sovarnum Capital's 13F filing for Q2 2018, filed 14 Aug 2018.